NO180239C - Ekspresjonsvektor som koder for, og kan uttrykke et polypeptid med de biologiske og immunologiske egenskapene til EqIFN-<gamma>, vertsorganisme transformert med denne, og fremgangsmåte for fremstilling av nevnte polypeptid - Google Patents
Ekspresjonsvektor som koder for, og kan uttrykke et polypeptid med de biologiske og immunologiske egenskapene til EqIFN-<gamma>, vertsorganisme transformert med denne, og fremgangsmåte for fremstilling av nevnte polypeptidInfo
- Publication number
- NO180239C NO180239C NO875136A NO875136A NO180239C NO 180239 C NO180239 C NO 180239C NO 875136 A NO875136 A NO 875136A NO 875136 A NO875136 A NO 875136A NO 180239 C NO180239 C NO 180239C
- Authority
- NO
- Norway
- Prior art keywords
- polypeptide
- gamma
- eqifn
- expressing
- biological
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/249—Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/57—IFN-gamma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19863642096 DE3642096A1 (de) | 1986-12-10 | 1986-12-10 | Pferde-(gamma)-interferon |
Publications (4)
Publication Number | Publication Date |
---|---|
NO875136D0 NO875136D0 (no) | 1987-12-09 |
NO875136L NO875136L (no) | 1988-06-13 |
NO180239B NO180239B (no) | 1996-12-02 |
NO180239C true NO180239C (no) | 1997-03-12 |
Family
ID=6315829
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO875136A NO180239C (no) | 1986-12-10 | 1987-12-09 | Ekspresjonsvektor som koder for, og kan uttrykke et polypeptid med de biologiske og immunologiske egenskapene til EqIFN-<gamma>, vertsorganisme transformert med denne, og fremgangsmåte for fremstilling av nevnte polypeptid |
Country Status (20)
Country | Link |
---|---|
US (1) | US5602010A (xx) |
EP (1) | EP0271824B1 (xx) |
JP (3) | JPS63233794A (xx) |
KR (1) | KR880007568A (xx) |
AT (1) | ATE91722T1 (xx) |
AU (1) | AU616873B2 (xx) |
CA (1) | CA1339776C (xx) |
DE (2) | DE3642096A1 (xx) |
DK (1) | DK170054B1 (xx) |
ES (1) | ES2058094T3 (xx) |
FI (1) | FI99116C (xx) |
HU (1) | HU213566B (xx) |
IE (1) | IE60404B1 (xx) |
IL (1) | IL84780A (xx) |
NO (1) | NO180239C (xx) |
NZ (1) | NZ222856A (xx) |
PH (1) | PH30889A (xx) |
PT (1) | PT86332B (xx) |
SU (1) | SU1701114A3 (xx) |
ZA (1) | ZA879245B (xx) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE56471T1 (de) | 1980-04-03 | 1990-09-15 | Biogen Inc | Dns-sequenzen, rekombinante dns-molekuele und verfahren zur herstellung von dem menschlichen fibroblast-interferon. |
US6307025B1 (en) | 1989-04-28 | 2001-10-23 | Biogen, Inc. | VCAM fusion proteins and DNA coding therefor |
US5272263A (en) | 1989-04-28 | 1993-12-21 | Biogen, Inc. | DNA sequences encoding vascular cell adhesion molecules (VCAMS) |
US7049102B1 (en) | 1989-09-22 | 2006-05-23 | Board Of Trustees Of Leland Stanford University | Multi-gene expression profile |
GB9414752D0 (en) * | 1994-07-21 | 1994-09-07 | Q One Biotech Ltd | Feline gamma-interferon |
GB2291645A (en) * | 1994-07-21 | 1996-01-31 | Q One Biotech Ltd | Equine gamma-interferon |
AU2587002A (en) * | 2000-11-03 | 2002-05-15 | Biomedicines Inc | Method for short-term and long-term drug dosimetry |
EP1536839B1 (en) * | 2001-11-09 | 2010-09-15 | Intarcia Therapeutics, Inc | Combination therapy comprising omega-interferon for treating infection with hepatitis c virus or yellow fever virus |
US7731947B2 (en) | 2003-11-17 | 2010-06-08 | Intarcia Therapeutics, Inc. | Composition and dosage form comprising an interferon particle formulation and suspending vehicle |
WO2006083761A2 (en) | 2005-02-03 | 2006-08-10 | Alza Corporation | Solvent/polymer solutions as suspension vehicles |
US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
AU2007266475B2 (en) | 2006-05-30 | 2009-12-03 | Intarcia Therapeutics, Inc. | Two-piece, internal-channel osmotic delivery system flow modulator |
DK2049081T3 (da) | 2006-08-09 | 2013-02-25 | Intarcia Therapeutics Inc | Osmotiske leveringssystemer og stempelarrangementer |
PT2157967E (pt) | 2007-04-23 | 2013-04-03 | Intarcia Therapeutics Inc | Formulações de suspensões de péptidos insulinotrópicos e suas utilizações |
DK2240155T3 (da) | 2008-02-13 | 2012-09-17 | Intarcia Therapeutics Inc | Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler |
KR102148624B1 (ko) | 2009-09-28 | 2020-08-26 | 인타르시아 세라퓨틱스 인코포레이티드 | 실질 항정상태 약물 전달의 신속 확립 및/또는 종결 |
US20120208755A1 (en) | 2011-02-16 | 2012-08-16 | Intarcia Therapeutics, Inc. | Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers |
US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
KR20240042548A (ko) | 2015-06-03 | 2024-04-02 | 인타르시아 세라퓨틱스 인코포레이티드 | 임플란트 배치 및 제거 시스템들 |
CN109310743A (zh) | 2016-05-16 | 2019-02-05 | 因塔西亚制药公司 | 胰高血糖素受体选择性多肽及其使用方法 |
USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
KR20190104039A (ko) | 2017-01-03 | 2019-09-05 | 인타르시아 세라퓨틱스 인코포레이티드 | Glp-1 수용체 효능제의 연속적인 투여 및 약물의 동시-투여를 포함하는 방법 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE88622C (xx) * | ||||
ZA811368B (en) * | 1980-03-24 | 1982-04-28 | Genentech Inc | Bacterial polypedtide expression employing tryptophan promoter-operator |
ZA831094B (en) * | 1982-02-22 | 1983-11-30 | Biogen Nv | Dna sequences,recombinant dna molecules and processes for producing human immune interferon-like polypeptides |
IE54592B1 (en) * | 1982-03-08 | 1989-12-06 | Genentech Inc | Anumal interferons, processes involved in their production, compositions containing them, dna sequences coding therefor and espression vehicles containing such sequences and cells transformed thereby |
DE3247922A1 (de) * | 1982-12-24 | 1984-06-28 | Boehringer Ingelheim International GmbH, 6507 Ingelheim | Dna-sequenzen, deren herstellung, diese sequenzen enthaltende plasmide und deren verwendung zur synthese eukaryotischer genprodukte in prokaryoten |
JPS60118196A (ja) * | 1983-11-30 | 1985-06-25 | Takeda Chem Ind Ltd | インタ−フェロンの製造法 |
US4666865A (en) * | 1984-01-13 | 1987-05-19 | Centocor, Inc. | Immunoassay for biologically active human interferon-gamma employing unique monoclonal antibodies |
DE3414831A1 (de) * | 1984-04-19 | 1985-10-31 | Hoechst Ag, 6230 Frankfurt | Herstellung von polypeptiden mit human-gammainterferon-aktivitaet |
FI90990C (fi) * | 1984-12-18 | 1994-04-25 | Boehringer Ingelheim Int | Rekombinantti-DNA-molekyyli, transformoitu isäntäorganismi ja menetelmä interferonin valmistamiseksi |
US4689224A (en) * | 1985-10-07 | 1987-08-25 | Neogen Corporation | Method for administering vaccines containing equine leukokines and compositions therefor |
DE3607835A1 (de) * | 1986-03-10 | 1987-09-24 | Boehringer Ingelheim Int | Hybridinterferone, deren verwendung als arzneimittel und als zwischenprodukte zur herstellung von antikoerpern und deren verwendung sowie verfahren zu ihrer herstellung |
CA1340698C (en) * | 1986-07-25 | 1999-08-10 | Kabushiki Kaisha Hayashibara Seibutsu Kaguku Kenkyujo | Preparation and uses of interferon-gamma |
US4908432A (en) * | 1987-01-09 | 1990-03-13 | New York University | Novel polypeptide having gamma-interferon activity |
-
1986
- 1986-12-10 DE DE19863642096 patent/DE3642096A1/de not_active Ceased
-
1987
- 1987-12-08 AU AU82233/87A patent/AU616873B2/en not_active Ceased
- 1987-12-09 IE IE334287A patent/IE60404B1/en not_active IP Right Cessation
- 1987-12-09 CA CA000553890A patent/CA1339776C/en not_active Expired - Fee Related
- 1987-12-09 ES ES87118264T patent/ES2058094T3/es not_active Expired - Lifetime
- 1987-12-09 HU HU875549A patent/HU213566B/hu not_active IP Right Cessation
- 1987-12-09 NO NO875136A patent/NO180239C/no unknown
- 1987-12-09 SU SU874203834A patent/SU1701114A3/ru active
- 1987-12-09 DK DK645887A patent/DK170054B1/da not_active IP Right Cessation
- 1987-12-09 NZ NZ222856A patent/NZ222856A/xx unknown
- 1987-12-09 EP EP87118264A patent/EP0271824B1/de not_active Expired - Lifetime
- 1987-12-09 ZA ZA879245A patent/ZA879245B/xx unknown
- 1987-12-09 AT AT87118264T patent/ATE91722T1/de not_active IP Right Cessation
- 1987-12-09 DE DE8787118264T patent/DE3786649D1/de not_active Expired - Fee Related
- 1987-12-10 IL IL84780A patent/IL84780A/xx not_active IP Right Cessation
- 1987-12-10 PT PT86332A patent/PT86332B/pt not_active IP Right Cessation
- 1987-12-10 JP JP62313130A patent/JPS63233794A/ja active Pending
- 1987-12-10 PH PH36200A patent/PH30889A/en unknown
- 1987-12-10 KR KR870014068A patent/KR880007568A/ko not_active Application Discontinuation
- 1987-12-10 FI FI875427A patent/FI99116C/fi not_active IP Right Cessation
-
1994
- 1994-06-17 US US08/263,214 patent/US5602010A/en not_active Expired - Fee Related
- 1994-12-12 JP JP6307981A patent/JPH07250690A/ja active Pending
- 1994-12-12 JP JP6307980A patent/JPH07258294A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO180239C (no) | Ekspresjonsvektor som koder for, og kan uttrykke et polypeptid med de biologiske og immunologiske egenskapene til EqIFN-<gamma>, vertsorganisme transformert med denne, og fremgangsmåte for fremstilling av nevnte polypeptid | |
DE3586189D1 (de) | Menge und verfahren zur herstellung rekombinierter erzeugnisse in grosser ausbeute. | |
YU193887A (en) | PROCESS FOR OBTAINING APOLYPOPROTEINE "Al" | |
DE69433690D1 (de) | Chimere proteine, welche borrelia polypeptide beinhalten, verwendungen dafür | |
DK491487A (da) | Dna-sekvens til ekspressionering af biologisk aktivt faktor xiii og anvendelse af samme | |
CA2066370A1 (en) | Yield when disulfide-bonded proteins are secreted | |
DK611386A (da) | Recombinant humant fsh, fremgangsmaade til fremstilling deraf og vektorer og celler til anvendelse ved fremgangsmaaden | |
DK1520860T3 (da) | Rekombinant protein PilC, fremgangsmåde til dets fremstilling og anvendelse deraf | |
DE3881023D1 (de) | Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten. | |
SE8601940D0 (sv) | Preparation of fused proteins, antibodies and processes therefor | |
DK595187D0 (da) | Minactivin og fremgangsmaade til fremstilling deraf | |
IL82962A0 (en) | Dna sequences containing a light inducible promoter derived from a myxobacterium and process for preparing polypeptides | |
DE3877136D1 (de) | Rekombinantes histidinreiches protein von plasmodium falciparum, seine herstellung und verwendung. | |
DK1241186T3 (da) | Humant vækststandsende specifikt gen-6 (gas-6) og nukleinsyrer kodende derfor | |
DE3876227D1 (de) | Malaria-spezifische dna-sequenzen, ihre expressionsprodukte und deren verwendung. | |
DK1241251T3 (da) | Humant prostasin-lignende protein og nukleinsyrer kodende for samme | |
DK1241183T3 (da) | Humant HCAR-agtig protein og nucleinsyrer kodende derfor |